$LJPC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LA JOLLA PHARMACEUTICAL CO. Get notifications about new insider transactions in LA JOLLA PHARMACEUTICAL CO for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.30 | 169 | 727 | 169 | |
| Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.66 | 169 | 618 | 3,934 | 3.8 K to 3.9 K (+4.49 %) |
| May 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 3.76 | 358 | 1,346 | 358 | |
| May 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.20 | 358 | 1,144 | 984 | 626 to 984 (+57.19 %) |
| May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.44 | 304 | 1,350 | 304 | |
| May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.77 | 304 | 1,147 | 626 | 322 to 626 (+94.41 %) |
| May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.44 | 163 | 724 | 163 | |
| May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.77 | 163 | 615 | 3,572 | 3.4 K to 3.6 K (+4.78 %) |
| May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 4.53 | 30,000 | 135,900 | 30,000 | |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.18 | 322 | 1,346 | 322 | |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.55 | 322 | 1,144 | 322 | 0 to 322 |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.18 | 322 | 1,346 | 322 | |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 | |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.55 | 322 | 1,144 | 322 | 0 to 322 |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.55 | 173 | 615 | 3,835 | 3.7 K to 3.8 K (+4.72 %) |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 | |
| Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.55 | 173 | 615 | 3,835 | 3.7 K to 3.8 K (+4.72 %) |
| Apr 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.24 | 172 | 729 | 172 | |
| Apr 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.60 | 172 | 620 | 3,662 | 3.5 K to 3.7 K (+4.93 %) |
| Mar 17 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 5.71 | 127 | 725 | 127 | |
| Mar 17 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.85 | 127 | 616 | 3,490 | 3.4 K to 3.5 K (+3.78 %) |
| Feb 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 6.71 | 535 | 3,590 | 535 | |
| Feb 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 5.70 | 535 | 3,051 | 3,224 | 2.7 K to 3.2 K (+19.90 %) |
| Feb 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 6.12 | 118 | 722 | 118 | |
| Feb 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 5.20 | 118 | 614 | 2,689 | 2.6 K to 2.7 K (+4.59 %) |
| Jan 20 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 5.35 | 136 | 728 | 136 | |
| Jan 20 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.55 | 136 | 618 | 1,094 | 958 to 1.1 K (+14.20 %) |
| Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.88 | 171 | 663 | 171 | |
| Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.30 | 171 | 564 | 958 | 787 to 958 (+21.73 %) |
| Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.88 | 171 | 663 | 171 | |
| Jan 05 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.30 | 171 | 564 | 958 | 787 to 958 (+21.73 %) |
| Dec 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.50 | 147 | 662 | 147 | |
| Dec 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.83 | 147 | 562 | 787 | 640 to 787 (+22.97 %) |
| Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Option Exercise | A | 4.53 | 30,000 | 135,900 | 30,000 | |
| Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Option Exercise | A | 4.53 | 30,000 | 135,900 | 30,000 | |
| Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.53 | 52,191 | 236,425 | 52,191 | |
| Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.53 | 278,350 | 1,260,926 | 278,350 | |
| Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | Rosen Robert | Director | Option Exercise | A | 4.53 | 30,000 | 135,900 | 30,000 | |
| Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 4.53 | 30,000 | 135,900 | 30,000 | |
| Dec 14 2020 | LJPC | LA JOLLA PHARMACEU ... | Johnson Laura L. | Director | Option Exercise | A | 4.53 | 30,000 | 135,900 | 30,000 | |
| Dec 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.97 | 134 | 666 | 134 | |
| Dec 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 4.23 | 134 | 566 | 640 | 506 to 640 (+26.48 %) |
| Nov 05 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.40 | 196 | 666 | 196 | |
| Nov 05 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 2.89 | 196 | 566 | 365 | 169 to 365 (+115.98 %) |
| Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.91 | 169 | 661 | 169 | |
| Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.32 | 169 | 561 | 169 | 0 to 169 |
| Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 3.91 | 169 | 661 | 169 | |
| Oct 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.32 | 169 | 561 | 169 | 0 to 169 |
| Sep 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.52 | 60,000 | 271,200 | 60,000 | |
| Sep 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.53 | 286 | 1,296 | 286 | |
| Sep 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.85 | 286 | 1,101 | 13,447 | 13.2 K to 13.4 K (+2.17 %) |
| Sep 10 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.83 | 1,000 | 3,830 | 48,000 | 47 K to 48 K (+2.13 %) |
| Sep 09 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.03 | 78,369 | 316,047 | 9,405,490 | 9.3 M to 9.4 M (+0.84 %) |
| Sep 09 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.01 | 48,296 | 193,894 | 9,327,121 | 9.3 M to 9.3 M (+0.52 %) |
| Sep 09 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 3.90 | 84,152 | 328,529 | 9,278,825 | 9.2 M to 9.3 M (+0.92 %) |
| Sep 09 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 3.82 | 67,552 | 258,359 | 9,194,673 | 9.1 M to 9.2 M (+0.74 %) |
| Sep 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.20 | 550 | 2,310 | 550 | |
| Sep 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.57 | 550 | 1,964 | 13,161 | 12.6 K to 13.2 K (+4.36 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.73 | 1,000 | 3,730 | 47,000 | 46 K to 47 K (+2.17 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.74 | 1,000 | 3,740 | 46,000 | 45 K to 46 K (+2.22 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.75 | 4,000 | 15,000 | 45,000 | 41 K to 45 K (+9.76 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.82 | 1,000 | 3,819 | 41,000 | 40 K to 41 K (+2.50 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.08 | 5,000 | 20,400 | 40,000 | 35 K to 40 K (+14.29 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.04 | 2,000 | 8,080 | 35,000 | 33 K to 35 K (+6.06 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.03 | 2,000 | 8,060 | 33,000 | 31 K to 33 K (+6.45 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.02 | 1,000 | 4,020 | 31,000 | 30 K to 31 K (+3.33 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.01 | 2,000 | 8,020 | 30,000 | 28 K to 30 K (+7.14 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.00 | 1,000 | 4,000 | 28,000 | 27 K to 28 K (+3.70 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.98 | 1,000 | 3,980 | 27,000 | 26 K to 27 K (+3.85 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.97 | 1,000 | 3,970 | 26,000 | 25 K to 26 K (+4.00 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.95 | 1,000 | 3,950 | 25,000 | 24 K to 25 K (+4.17 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.94 | 2,000 | 7,888 | 24,000 | 22 K to 24 K (+9.09 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.93 | 1,000 | 3,930 | 22,000 | 21 K to 22 K (+4.76 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.92 | 1,000 | 3,920 | 21,000 | 20 K to 21 K (+5.00 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.90 | 1,000 | 3,900 | 20,000 | 19 K to 20 K (+5.26 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.88 | 1,000 | 3,880 | 19,000 | 18 K to 19 K (+5.56 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.87 | 1,000 | 3,870 | 18,000 | 17 K to 18 K (+5.88 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.86 | 1,000 | 3,860 | 17,000 | 16 K to 17 K (+6.25 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.85 | 2,000 | 7,700 | 16,000 | 14 K to 16 K (+14.29 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 3.84 | 2,000 | 7,680 | 14,000 | 12 K to 14 K (+16.67 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.18 | 2,530 | 10,575 | 12,000 | 9.5 K to 12 K (+26.72 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.17 | 3,470 | 14,470 | 9,470 | 6 K to 9.5 K (+57.83 %) |
| Aug 24 2020 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Buy | P | 4.17 | 6,000 | 25,015 | 6,000 | 0 to 6 K |
| Aug 18 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 3.93 | 589 | 2,315 | 589 | |
| Aug 18 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.34 | 589 | 1,967 | 12,611 | 12 K to 12.6 K (+4.90 %) |
| Aug 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 3.98 | 581 | 2,312 | 581 | |
| Aug 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.38 | 581 | 1,964 | 12,022 | 11.4 K to 12 K (+5.08 %) |
| Jul 29 2020 | LJPC | LA JOLLA PHARMACEU ... | LA JOLLA PHARMACEUTICAL CO | 10% Owner | Buy | P | 2.00 | 3,737,360 | 7,474,720 | 4,822,360 | 1.1 M to 4.8 M (+344.46 %) |
| Jul 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.44 | 521 | 2,313 | 521 | |
| Jul 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.77 | 521 | 1,964 | 11,441 | 10.9 K to 11.4 K (+4.77 %) |
| Jul 01 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.26 | 543 | 2,313 | 543 | |
| Jul 01 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.62 | 543 | 1,966 | 10,920 | 10.4 K to 10.9 K (+5.23 %) |
| Jun 22 2020 | LJPC | LA JOLLA PHARMACEU ... | LA JOLLA PHARMACEUTICAL CO | 10% Owner | Buy | P | 2.62 | 234,698 | 613,993 | 1,085,000 | 850.3 K to 1.1 M (+27.60 %) |
| Jun 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 5.31 | 435 | 2,310 | 435 | |
| Jun 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 4.51 | 435 | 1,962 | 10,377 | 9.9 K to 10.4 K (+4.38 %) |
| Jun 04 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.94 | 215,812 | 1,065,636 | 8,695,474 | 8.5 M to 8.7 M (+2.55 %) |
| Jun 04 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.90 | 145,764 | 714,783 | 8,479,662 | 8.3 M to 8.5 M (+1.75 %) |
| Jun 04 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.88 | 253,553 | 1,237,060 | 8,333,898 | 8.1 M to 8.3 M (+3.14 %) |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 4.72 | 82 | 387 | 82 | |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 4.01 | 82 | 329 | 5,067 | 5 K to 5.1 K (+1.64 %) |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.72 | 491 | 2,318 | 491 | |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 4.01 | 491 | 1,969 | 9,942 | 9.5 K to 9.9 K (+5.20 %) |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 4.72 | 205 | 968 | 205 | |
| Jun 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 4.01 | 205 | 822 | 81,771 | 81.6 K to 81.8 K (+0.25 %) |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.89 | 56 | 386 | 56 | |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.86 | 56 | 328 | 4,985 | 4.9 K to 5 K (+1.14 %) |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.89 | 335 | 2,308 | 335 | |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.86 | 335 | 1,963 | 9,451 | 9.1 K to 9.5 K (+3.67 %) |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.89 | 140 | 965 | 140 | |
| May 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.86 | 140 | 820 | 81,566 | 81.4 K to 81.6 K (+0.17 %) |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.26 | 133 | 966 | 133 | |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.17 | 133 | 821 | 81,426 | 81.3 K to 81.4 K (+0.16 %) |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 7.26 | 319 | 2,316 | 319 | |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 6.17 | 319 | 1,968 | 9,116 | 8.8 K to 9.1 K (+3.63 %) |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 7.26 | 53 | 385 | 53 | |
| May 04 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 6.17 | 53 | 327 | 4,929 | 4.9 K to 4.9 K (+1.09 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.60 | 58 | 383 | 58 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.61 | 58 | 325 | 4,876 | 4.8 K to 4.9 K (+1.20 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.60 | 34 | 224 | 34 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.61 | 34 | 191 | 9,504 | 9.5 K to 9.5 K (+0.36 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.60 | 350 | 2,310 | 350 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.61 | 350 | 1,964 | 8,797 | 8.4 K to 8.8 K (+4.14 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.60 | 146 | 964 | 146 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.61 | 146 | 819 | 81,293 | 81.1 K to 81.3 K (+0.18 %) |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.20 | 165 | 693 | 165 | |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.57 | 165 | 589 | 8,447 | 8.3 K to 8.4 K (+1.99 %) |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 4.20 | 459 | 1,928 | 459 | |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 3.57 | 459 | 1,639 | 9,470 | 9 K to 9.5 K (+5.09 %) |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 4.20 | 229 | 962 | 229 | |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 3.57 | 229 | 818 | 81,147 | 80.9 K to 81.1 K (+0.28 %) |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 4.00 | 241 | 964 | 241 | |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 3.40 | 241 | 819 | 80,918 | 80.7 K to 80.9 K (+0.30 %) |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 4.00 | 483 | 1,932 | 483 | |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 3.40 | 483 | 1,642 | 9,011 | 8.5 K to 9 K (+5.66 %) |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.00 | 173 | 692 | 173 | |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.40 | 173 | 588 | 8,282 | 8.1 K to 8.3 K (+2.13 %) |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.80 | 142 | 966 | 142 | |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.78 | 142 | 821 | 80,677 | 80.5 K to 80.7 K (+0.18 %) |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.80 | 102 | 694 | 102 | |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.78 | 102 | 590 | 8,109 | 8 K to 8.1 K (+1.27 %) |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.80 | 284 | 1,931 | 284 | |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.78 | 284 | 1,642 | 8,528 | 8.2 K to 8.5 K (+3.44 %) |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.40 | 229 | 1,924 | 229 | |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.14 | 229 | 1,635 | 8,244 | 8 K to 8.2 K (+2.86 %) |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.40 | 83 | 697 | 83 | |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.14 | 83 | 593 | 8,007 | 7.9 K to 8 K (+1.05 %) |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.40 | 115 | 966 | 115 | |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.14 | 115 | 821 | 80,535 | 80.4 K to 80.5 K (+0.14 %) |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.85 | 101 | 692 | 101 | |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.82 | 101 | 588 | 7,924 | 7.8 K to 7.9 K (+1.29 %) |